In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 850-854

  Seifert, Karin ^a   Munday, Jane ^a,b   Syeda, Tahmina ^a,c   Croft, Simon L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Pharmidex   (United Kingdom)

Author keywords

Drug development; Leishmaniasis; Synergism

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SITAMAQUINE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG; ZENTARIS;

AMASTIGOTE; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SENSITIVITY; IN VITRO STUDY; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PARASITE ISOLATION; PERITONEUM MACROPHAGE;

ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; CRICETINAE; DRUG INTERACTIONS; DRUG RESISTANCE; LEISHMANIA DONOVANI; MACROPHAGES, PERITONEAL; MICE;

EID: 79952795685     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq542     Document Type: Article

References (10)

1. Chappuis F, Sundar S, Hailu A et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007; 5: 873-82.
2. Sundar S, Rai M, Chakravarty J et al. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 2008; 47: 1000-6.
3. Kinnamon KE, Steck EA, Loizeaux PS et al. The antileishmanial activity of lepidines. Am J Trop Med Hyg 1978; 27: 751-7.
4. Jha TK, Sundar S, Thakur CP et al. A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. Am J Trop Med Hyg 2005; 73: 1005-11.
5. Wasunna MK, Rashid JR, Mbui J et al. A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya. Am J Trop Med Hyg 2005; 73: 871-6.
6. Seifert K, Croft SL. Invitro and invivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother 2006; 50: 73-9.
7. Kremsner PG, Krishna S. Antimalarial combinations. Lancet 2004; 364: 285-94.
8. Olliaro PL, Guerin PJ, Gerstl S et al. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763-74.
9. Jia J, Zhu F, Ma X et al. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 2009; 8: 111-28.
10. 2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ. Biochem J 1992; 284: 463-7.